The company's innovation marks “a groundbreaking step toward lowering infant mortality.”
Health Care + Med Tech
To answer a growing demand for orthopedics, Fairview is strengthening its ties to Summit.
Negotiations may lack a real deadline, and the parties may still resist needed compromises and recognition of actual bargaining leverage.
A state grant will allow the medical benefits group to deliver non-pharmalogical treatments to underserved areas of the Twin Cities.
The Minneapolis-based medtech company can now market its wearable sensor to hospitals and cancer centers.
The goal of the new prescription-dispensing facility is to free up pharmacists for patient care.
The medical device maker has unveiled plans to spin off its diabetes business unit into its own publicly traded company that would be headquartered in California.
The Chanhassen-based company plans to use the funds on a randomized trial of its “sonodynamic therapy” for glioblastoma, a deadly type of brain cancer.
Former chief executive Stephen Hemsley will replace Witty. The insurer also reportedly faces a Department of Justice investigation.
Minnesota’s attorney general says that Surmodics’ plan to get acquired by a Chicago-based private equity firm is “anticompetitive.”
The Dutch multinational giant says it will hire about 150 people locally as a result of the expansion.
This Arden Hills startup is reimagining X-ray protection for medical staff.
The concept has expanded significantly in recent years, three panelists said at a TCB Talks panel discussion at the Minneapolis Club on Thursday.
Cleo Skin and Laser is moving the needle in tattoo removal, making the service feel luxurious (and less painful).
The university and Fairview welcomed the attorney general’s intervention amid an impasse over a new partnership with Duluth-based Essentia.
State research shows parts of Minnesota that have either low or limited pharmacy access.
The Rochester-based nonprofit health system’s operating income hit nearly $1.3 billion in 2024.
Long heralded as a balm for America's troubled health care system, outcome-based insurer reimbursement has yet to find its foothold.